A study on oxidative modification of low-density lipoprotein and the response of vascular endothelial cells

低密度脂蛋白氧化修饰及血管内皮细胞反应的研究

基本信息

  • 批准号:
    14370792
  • 负责人:
  • 金额:
    $ 7.1万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2004
  • 项目状态:
    已结题

项目摘要

Radical species cause oxidative modification of low-density lipoprotein(LDL), which plays a key role in the very early stage of atherogenesis. However, the exact mechanism how oxidized LDL acts as an initiator of atherosclerosis and what causes abonormal signals in the endothelial cells are not still clear. In this study, we conducted experiments as how LDL is oxidized, what kind of modification plays an important role for the endothelial cells.First we examined the structure of sugar chain on the LDL particles and identified eight types of sugar chains. There was no significant difference between native LDL and oxidized LDL in the structure. When we released mannose by adding an enzyme, a significant prolongation of the lag phase was observed Second we analyzed the amino acid sequence of each fragment that was generated by oxidation of LDL, and found that various serum proteins such as apolipoprotein A-I, fibrin, α2-macrqglobulin, haptoglobin, etc. were non-specifically bound to LDL. … More Finally we established a method to purify thus contaminated LDL by using gel permeation chromatography, and obtained purified fragments of oxidized LDL.We already found that vascular endothelial adhesion molecule-1(VCAM-1) expressed on the endothelial cells by the stimulation of oxidized LDL. VCAM-1 plays a key role to adhere macophages in the every early stage of atherogenesis. So we conducted experiments to examine whether the level of messenger RNA(mRNA) of VCAM-1 would rise or not by adding purified oxidized LDL. First we added IL-1 to the endothelial cells by changing its concentration and incubation time. It was found that two hours incubation was the most effective time to induce mRNA of VCAM-1. Finally we succeeded in finding the most appropriate condition and observing the induction of mRNA of VCAM-1 by adding fragments of oxidized LDL.Another result of the study was to find a method to estimate three-dimensional structure of apolipoprotein B-100(apoB-100). Because of its extraordinary size and insoluble nature, the three dimensional structure has been difficult to deduce. The method was developed based on the consideration that sites of α-helices with higher hydrophilicity are more likely to combine with each other and form bundles in the non-polar environment. Two cylinder models were established and the interactive force (E) between them was calculated according to hydrophobicity and the charge on the amino acids. Consequently, a series of values of E ranging from 383 to 7315 was obtained. Extremely high E values were considered to represent regions of α-helices. If we combined the regions in close proximity to each other, 5 candidates for α-helix bundles were identified. These regions matched well with the lipid-binding motifs of apoB-100 as reported by others. Thus, our algorithm was useful in predicting the higher-order structure of apoB-100, and proper use of this method may enable identification of potential lipid-associating domains of membrane proteins. Less
自由基引起低密度脂蛋白(LDL)的氧化修饰,这在动脉粥样硬化形成的早期阶段起着关键作用。然而,氧化低密度脂蛋白作为动脉粥样硬化的引发剂的确切机制以及导致内皮细胞异常信号的原因仍然不清楚。在本研究中,我们进行了实验,如何LDL被氧化,什么样的修饰对内皮细胞起着重要的作用。首先,我们检查了LDL颗粒上的糖链结构,并确定了八种糖链。天然LDL与氧化LDL在结构上无明显差异。当我们通过加入酶释放甘露糖时,观察到滞后期显著延长。其次,我们分析了LDL氧化产生的每个片段的氨基酸序列,发现各种血清蛋白如载脂蛋白A-I、纤维蛋白、α2-巨球蛋白、触珠蛋白等与LDL非特异性结合。 ...更多信息 最后,我们建立了一种用凝胶渗透色谱法纯化氧化LDL的方法,得到了纯化的氧化LDL片段。我们已经发现,血管内皮细胞粘附分子-1(VCAM-1)在氧化LDL的刺激下在内皮细胞上表达。VCAM-1在动脉粥样硬化形成的各个早期阶段起着粘附巨噬细胞的关键作用。因此,我们进行了实验,以检查VCAM-1的信使RNA(mRNA)的水平是否会增加或不加入纯化的氧化LDL。首先,我们通过改变IL-1的浓度和孵育时间将其加入内皮细胞。结果发现,孵育2小时是诱导VCAM-1 mRNA表达的最有效时间。本研究的另一个结果是找到一种估算载脂蛋白B-100(apoB-100)三维结构的方法。由于其非凡的尺寸和不溶性,三维结构一直难以推断。该方法是基于考虑到具有较高亲水性的α-螺旋的位点在非极性环境中更容易彼此联合收割机并形成束而开发的。建立了两个圆柱体模型,并根据疏水性和氨基酸上的电荷计算了它们之间的相互作用力(E)。因此,获得了一系列范围从383到7315的E值。认为极高的E值代表α-螺旋区域。如果我们将这些区域彼此紧密结合,则确定了5个α-螺旋束的候选者。这些区域与其他人报道的apoB-100的脂质结合基序匹配良好。因此,我们的算法在预测apoB-100的高阶结构中是有用的,并且适当地使用这种方法可以识别膜蛋白的潜在脂质相关结构域。少

项目成果

期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A new method of measuring the antioxidant activity of polyphenols using cumene hydroperoxidase.
使用枯烯氢过氧化物酶测量多酚抗氧化活性的新方法。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    O.Sugita;N.Ishizawa;T.Matsuto;M.Okada;N.Kayahara
  • 通讯作者:
    N.Kayahara
T13M mutation of lecithin-cholesterol acyltranseferase gene causes fish-eye disease.
卵磷脂胆固醇酰基转移酶基因T13M突变导致鱼眼病。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T.Miida;B.Zhang;K.Obayashi;Y.Seino;Y.Zhu;T.Ito;Y.Nakamura;M.Okada;K.Saku
  • 通讯作者:
    K.Saku
Risk of carotid artery atherosclerosis : a prospective study in non-diabetic subjects (Niigata Study)
颈动脉粥样硬化的风险:非糖尿病受试者的前瞻性研究(新泻研究)
Seitaro Maruyama: "Fenofibrate, a peroxisome proliferator-activated receptor α activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10"J. Atheroscler. Thromb.. 9・2. 87-92 (2002)
Seitaro Maruyama:“非诺贝特,一种过氧化物酶体增殖物激活受体 α 激活剂,通过刺激白细胞介素 10 抑制实验性自身免疫性心肌炎”J. Thromb.. 87-92。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takashi Miida: "LACT-dependent conversion of pre β1-HDL into α-migrating HDL is severely delayed in hemodialysis patients"J.Am.Soc.Nephrol.. 14. 732-738 (2003)
Takashi Miida:“血液透析患者中​​前 β1-HDL 向 α-迁移 HDL 的 LACT 依赖性转化严重延迟”J.Am.Soc.Nephrol.. 14. 732-738 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKADA Masahiko其他文献

OKADA Masahiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKADA Masahiko', 18)}}的其他基金

Empirical Study on Training and Supporting supervisors of Social Education
社会教育督导员培训与支持实证研究
  • 批准号:
    17K04632
  • 财政年份:
    2017
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structure-Controlled Synthesis of Polyesteramides Utilizing Sugar Diols and Amino Acids
利用糖二醇和氨基酸结构控制合成聚酯酰胺
  • 批准号:
    16550113
  • 财政年份:
    2004
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
RESEARCH ON THE EFFECIENCY OF RECORDS OF CLASSES UTILIZING MULTI-MEDIA TOOLS
利用多媒体工具进行课堂记录的有效性研究
  • 批准号:
    16500596
  • 财政年份:
    2004
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Chemical Synthesis of Biodegradable Polyesters Utilizing Sugar Biomasses.
利用糖生物质化学合成可生物降解聚酯。
  • 批准号:
    11217208
  • 财政年份:
    1999
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Development of Biodegradable Biopolymer Hybrid Materials
可生物降解生物聚合物杂化材料的开发
  • 批准号:
    11555248
  • 财政年份:
    1999
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Precision Synthesis of Glycopeptide-Type Sugar Balls and Development of Their Molecular Catalyst and Molecular Recognition
糖肽型糖球的精密合成及其分子催化剂和分子识别的开发
  • 批准号:
    09450349
  • 财政年份:
    1997
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of epitopes for antibodies against oxidized lipoprotein and development of the assay system
氧化脂蛋白抗体表位分析及检测系统开发
  • 批准号:
    09557216
  • 财政年份:
    1997
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Novel Biodegradable Polymers Based on Carbohydrate Biomass.
基于碳水化合物生物质的新型可生物降解聚合物的开发。
  • 批准号:
    08555234
  • 财政年份:
    1996
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Synthesis of Cell-Recognizable Sugar-Peptide Conjugates by Living Ring-Opening Polymerization
通过开环聚合合成细胞可识别的糖肽缀合物
  • 批准号:
    07651081
  • 财政年份:
    1995
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Roles and Expression Mechanisms of Cellular Adhesion Molecules during the Initiation of Arteriosclerosis
细胞粘附分子在动脉硬化发生过程中的作用及表达机制
  • 批准号:
    07457562
  • 财政年份:
    1995
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

钙调蛋白激酶PNCK磷酸化p38/MAPK通路调控黏附因子VCAM-1表达诱导肿瘤-血管定植促进肝癌播散的机制研究
  • 批准号:
    QN25H160126
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
VCAM-1通过激活巨噬细胞参与衰老相关心房重构及其机制研究
  • 批准号:
    82370332
  • 批准年份:
    2023
  • 资助金额:
    47 万元
  • 项目类别:
    面上项目
高醛条件下IRF-1诱导VCAM-1 生成调控血管钙化的机制研究
  • 批准号:
    2022JJ30799
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于铁死亡探讨VCAM-1阳性间充质干细胞外泌体修复老年糖尿病心肌损伤的作用与机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
E2F2转录调控VCAM-1诱导多发性骨髓瘤耐药的机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
靶向VCAM-1的嵌合抗原受体调节性T细胞免疫疗法治疗腹主动脉瘤的实验研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
ITGα4β1/VCAM-1调控iPSC治疗PM2.5诱发肺损伤的作用及机制研究
  • 批准号:
    82100022
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MicroRNA-122调控VCAM-1/NOS2发挥脑保护作用的研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
高效抑制VCAM-1的仿生杂合NO前药自组装纳米粒用于乳腺癌及肺转移的治疗研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Control of systemic progression of pancreatic cancer by blocking VCAM-1: a study of genetically-engineered mouse model
通过阻断 VCAM-1 控制胰腺癌的全身进展:基因工程小鼠模型的研究
  • 批准号:
    20K07584
  • 财政年份:
    2020
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting VCAM-1 for contributing to the prognosis of pancreatic cancer: the effect and underlying mechanisms
靶向VCAM-1有助于胰腺癌的预后:效果和潜在机制
  • 批准号:
    17K07155
  • 财政年份:
    2017
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
膵癌の治療奏功性・抵抗性におけるVCAM-1の機能解析と臨床における有用性
VCAM-1 在胰腺癌治疗反应/耐药和临床用途中的功能分析
  • 批准号:
    26430107
  • 财政年份:
    2014
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating epallelic heterogeneity at the promoter of the Vascular Cell Adhesion Molecule-1 (VCAM-1) in endothelial cells.
研究内皮细胞中血管细胞粘附分子 1 (VCAM-1) 启动子的等位异质性。
  • 批准号:
    182235
  • 财政年份:
    2009
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Studentship Programs
Longitudinal assessment of the effect of exercise on endothelial inflammation and endothelial function in a swine model of atherosclerosis using contrast-enhanced ultrasound imaging with non targeted and targeted (anti-VCAM-1)- microbubbles.
使用非靶向和靶向(抗 VCAM-1)微泡的对比增强超声成像纵向评估运动对猪动脉粥样硬化模型中内皮炎症和内皮功能的影响。
  • 批准号:
    185769
  • 财政年份:
    2009
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Fellowship Programs
Knock-down von VCAM-1 durch rekombinante Antikörper
重组抗体敲低 VCAM-1
  • 批准号:
    5448278
  • 财政年份:
    2005
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Research Units
gp91 phox Function in VCAM-1-dependent Lung Eosinophilia
gp91 phox 在 VCAM-1 依赖性肺嗜酸性粒细胞增多中的功能
  • 批准号:
    7382590
  • 财政年份:
    2005
  • 资助金额:
    $ 7.1万
  • 项目类别:
gp91 phox Function in VCAM-1-dependent Lung Eosinophilia
gp91 phox 在 VCAM-1 依赖性肺嗜酸性粒细胞增多中的功能
  • 批准号:
    7223070
  • 财政年份:
    2005
  • 资助金额:
    $ 7.1万
  • 项目类别:
VLA-4 and VCAM-1 in Advanced Atherosclerosis
VLA-4 和 VCAM-1 在晚期动脉粥样硬化中的作用
  • 批准号:
    7140037
  • 财政年份:
    2005
  • 资助金额:
    $ 7.1万
  • 项目类别:
gp91 phox Function in VCAM-1-dependent Lung Eosinophilia
gp91 phox 在 VCAM-1 依赖性肺嗜酸性粒细胞增多中的功能
  • 批准号:
    7228225
  • 财政年份:
    2005
  • 资助金额:
    $ 7.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了